EHRA Premium Access

Mechanism, follow-up and recurrence of inappropriate therapy in the PRAETORIAN trial: action reduces recurrence

Topic: Implantable Cardioverter-Defibrillator (ICD)

Congress Presentation

About the speaker

Miss Shari Pepplinkhuizen

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
1 presentation
0 follower

131 more presentations in this session

Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion

Speaker: Doctor L. Sgarra (Acquaviva Delle Fonti, IT)

Thumbnail

Pure and impure tachycardiomiopathy: key differences and long term prognosis

Speaker: Doctor G. Stronati (Ancona, IT)

Thumbnail

Prognostic value of plasma neutrophil gelatinase-associated lipocalin for cardiovascular events in patients with chronic heart failure and atrial fibrillation

Speaker: Professor D. Lashkul (Zaporizhzhia, UA)

Thumbnail

Interatrial block as a prognosticator of new-onset atrial fibrillation: prospective observational study of 8012 adults

Speaker: Mr E. Abdovic (Zenica, BA)

Thumbnail

CHA2DS2-VASc score and the risk of death in atrial fibrillation

Speaker: Doctor A. Aro (Helsinki, FI)

Thumbnail

Access the full session

ePosters Day 2

Speakers: Miss S. Pepplinkhuizen, Doctor L. Sgarra, Doctor G. Stronati, Professor D. Lashkul, Mr E. Abdovic...
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Related content

EHRA Premium Access

Comparative of stylet-driven versus lumenless technique for left bundle branch pacing: implant results and follow-up outcomes

5 April 2022

EHRA Premium Access

Conduction system pacing in paediatric patients: a single centre experience

3 April 2022

ESC 365 is supported by

logo Novo Nordisk